Mark S. Kipnes

7.4k citations
72 papers · 6.1k · 4 hit papers · h-index 34

Impact in

Papers in

    • Diabetes Management and Research 25
    • Diabetes Treatment and Management 18
    • Hormonal and reproductive studies 4
    • Growth Hormone and Insulin-like Growth Factors 3
    • Lipoproteins and Cardiovascular Health 3
    • Bariatric Surgery and Outcomes 2

Mark S. Kipnes

70 papers receiving 5.6k citations

Mark S. Kipnes's Hit Papers

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes 2021 · 177 citations
1770+6+13Years since publication250500750

Peers

Mark S. Kipnes
Comparison fields: 5 of 89
  • Endocrinology, Diabetes and Metabolism 3.4k
  • Gastroenterology 105
  • Epidemiology 398
  • Pharmaceutical Science 54
  • Behavioral Neuroscience 15
Replace Geremia B. Bolli with:
Geremia B. Bolli Italy
Robert L. Dobbins United States
Marek Bolanowski Poland
Meng Hee Tan United States
Arihiro Kiyosue Japan
Axel Haupt United States
Marek Ruchała Poland
Antonio Bianchi Italy
Mark M. Smits Netherlands
Freddy Goldberg Eliaschewitz Brazil
Mark S. Kipnes relative to Geremia B. Bolli Italy Geremia B. Bolli's profile →
Citations per field
00.5×2×4×5.8×
Geremia B. Bolli · 1×
Citations per year

Countries citing papers authored by Mark S. Kipnes

Since Specialization
Citations

This map shows the geographic impact of Mark S. Kipnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Kipnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Kipnes more than expected).

Fields of papers citing papers by Mark S. Kipnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Kipnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Kipnes. The network helps show where Mark S. Kipnes may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Kipnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Kipnes Line = papers co-authored together Mark S. Kipnes links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Hit paper breakdown →
2013825
2
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Hit paper breakdown →
2006754
3 2006440
4 2007434
5
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Hit paper breakdown →
2012398
6 2001234
7
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Hit paper breakdown →
2021177
8 2004149
9 2012145
10 2008144
11 2006143
12 1998126
13 2022122
14 2020111
15 2017103
16 199497
17 200487
18 201278
19 200677
20 200369

About Mark S. Kipnes

Mark S. Kipnes is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Gastroenterology and Epidemiology, having authored 72 papers that have together received 6.1k indexed citations. Recurring topics across this work include Diabetes Management and Research (25 papers), Diabetes Treatment and Management (18 papers), Hormonal and reproductive studies (4 papers), Blood Pressure and Hypertension Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Bariatric Surgery and Outcomes (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Gastroenterology (105 citations), Epidemiology (398 citations), Pharmaceutical Science (54 citations) and Behavioral Neuroscience (15 citations). Mark S. Kipnes has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Debora Williams‐Herman, Jared K. Lunceford, Carolyn Mickel, Pablo J. Aschner, Arun Jayant Sanyal, Paul Clopton, Hanns–Ulrich Marschall, Sunder Raj D. Mudaliar, Linda Morrow and Robert R. Henry. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes Care, The Journal of Clinical Endocrinology & Metabolism, Journal of Diabetes Science and Technology and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact